← All Srax, INC filings

Srax, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
SRAX
Srax, INC
8-K: SRAX to Merge with Web3 Investment Firm DNA Holdings, Creating New Publicly Traded Entity
SRAX Inc. has entered into a definitive merger agreement with DNA Holdings Venture Inc., which will result in DNA's shareholders becoming the majority owners of SRAX's outstanding common stock.
OTC.Pink
SRAX
Srax, INC
8-K: SRAX, Inc. Secures $75,000 in Funding Through Convertible Promissory Note
SRAX, Inc. has entered into a securities purchase agreement for a $90,000 convertible promissory note, with an original issue discount, resulting in $75,000 in funding.
OTC.Pink
SRAX
Srax, INC
8-K: SRAX Inc. Amends Preferred Stock Terms, Removes Shareholder Approval Requirement
SRAX Inc. has amended the terms of its Series B Preferred Stock, removing the need for shareholder approval for certain issuances and expanding trading market options.
OTC.Pink
SRAX
Srax, INC
8-K: SRAX, Inc. Secures $75,000 in Funding Through Convertible Promissory Note
SRAX, Inc. has entered into an agreement to issue a convertible promissory note for $75,000, with a principal amount of $90,000, convertible into common stock at $0.25 per share.